Bristol-Myers Squibb Company
NYSE: BMY
$46.92
+$0.06 (+0.13%)
Closing Price on June 23, 2025
BMY Articles
Johnson & Johnson has rewarded shareholders again with a quarterly dividend. As a Dividend King, it is the epitome of a steady and reliable stock.
Published:
Four top companies all pay at least a 4% dividend are on sale and make sense for investors who may be worried about increased volatility in the stock market.
Published:
AbbVie just rewarded its shareholders again with a dividend. This stock has boosted its payout annually for more than 50 years.
Published:
Live Updates Live Coverage Has Ended Deep Dive into ABBV's Earnings Call 11:53 am by Rich Duprey Looking through AbbVie’s earnings call, these growth prospects stood out: 1. Skyrizi & Rinvoq...
Published:
Dependable recurring dividends from quality, high-yield stocks like these five are a recipe for passive income success.
Published:
Merck just rewarded its shareholders again with a dividend hike. This Dow Jones industrial stock has come with a quarterly dividend for almost two decades.
Published:
Last Updated:
Here are seven blue-chip dividend stocks that investors can buy now and hold forever, as they provide a steady stream of passive income and offer promising total return.
Published:
Johnson & Johnson has rewarded shareholders again with a quarterly dividend. As a Dividend King, it is the epitome of a steady and reliable stock.
Published:
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Donald Trump’s victory is positive for the stock...
Published:
Investors can buy these five top passive income dividend stocks and hold them for the long haul. Top Wall Street firms rate them all at Buy.
Published:
24/7 Wall St. Insights: AbbVie (ABBV) took a big hit after an adult schizophrenia drug missed its primary endpoint in mid-stage trials. Analysts are now questioning the pharma’s pipeline, raising...
Published:
These six high-yield dividend stocks are universally loved by investment professionals and they now offer reasonable entry points.
Published:
AbbVie has rewarded shareholders again with a quarterly dividend. As a Dividend King, it is the epitome of a steady and reliable stock.
Published:
24/7 Wall St. Insights The seemingly endless political season is almost over. It’s possible we won’t know the winner for a while. Sit back and let dividends do the heavy lifting for a simple,...
Published:
Here are three quality blue chip passive income stocks that are still reasonably priced and are rated Buy at top Wall Street firms.
Published:
